This review highlights advancements in diagnosing and treating candidemia, focusing on risk factors and antifungal effectiveness.
Key Points
Candidemia shows increased prevalence in patients with steroid-induced immunosuppression, indicating a need for vigilant monitoring during transplantation.
New diagnostic methods, including biomarker panels and biosensors, significantly enhance the detection of Candida species.
Antifungals like micafungin and newer options such as rezafungin improve survival rates in patients with obesity and candidemia.
Understanding the role of gut microbiota in candidemia risk can help tailor treatment and prevention strategies for affected individuals.
Cite This Study
Cabrera-Guerrero et al. (2025) studied this question.